VIVAN THERAPEUTICS
VIVAN THERAPEUTICS
Status:
Active
Total Funding:
0
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Minutia
Biotech, Therapeutics
Investors List
Reflect Ventures
Reflect Ventures investment in Series A - Vivan Therapeutics
More informations about "Vivan Therapeutics"
Home - Vivan Therapeutics
Vivan Therapeutics' Personal Discovery Process provides individuals with personalised cancer treatment and cancer treatment research on an unprecedented scale.See details»
VIVAN Therapeutics - Crunchbase Company Profile
VIVAN Therapeutics, a company pioneering personalized cancer therapeutics using a new assay technology. MPT licensed technology from the Center for Personalized Cancer Therapeutics at Mt Sinai New York and is launching the โฆSee details»
Vivan Therapeutics - PitchBook
Vivan Therapeutics is headquartered in London, United Kingdom. What is the size of Vivan Therapeutics? Vivan Therapeutics has 20 total employees. What industry is Vivan Therapeutics in? Vivan Therapeuticsโs primary industry is โฆSee details»
Patient - Vivan Therapeutics
Learn how Vivan Therapeutics can help you on your cancer treatment journey and access the best possible personalised therapeutics.See details»
Biopharma - Vivan Therapeutics
We help direct the treatment of cancer patients, enabling the rapid identification of combination therapies to treat polygenic diseases, as well as providing our Biopharma partners with patient-relevant models to test novel therapies and โฆSee details»
Vivan Therapeutics - LinkedIn
About us. Personalised cancer therapeutics platform pioneered at Mount Sinai Medical Center. Website. https://vivantx.com/ Industry. Biotechnology Research. Company size. 11-50 employees....See details»
VIVAN Therapeutics - Funding, Financials, Valuation & Investors
VIVAN Therapeutics is a company pioneering personalized cancer therapeutics using a new assay technology.See details»
Vivan Therapeutics - WISH
Vivan Therapeutics offers personalized cancer therapeutics utilizing technology developed at and in partnership with Mt Sinai Medical Center, New York. The company identifies personalized โฆSee details»
UK Vivan Therapeutics Secures Expanded Drug Discovery
May 24, 2021ย ยท With its proprietary screening data, Vivan Therapeutics is building a powerful AI-driven digital health tool, which can potentially predict effective treatment options rapidly and โฆSee details»
Vivan Therapeutics Partners with Canadian Medical Provider โฆ
Oct 26, 2022ย ยท Toronto, ON, and London, UK, October 26, 2022 โ Vivan Therapeutics (โVivanโ), a London-based biotechnology company, and Gotodoctor.ca, a leading Canadian healthcare โฆSee details»
Laura Towart, CEO Vivan Therapeutics โ Granatus Ventures
Mar 13, 2023ย ยท A neuroscientist by training with a passion for personalized medicine, Laura began building Vivan (formerly known as My Personal Therapeutics) over a decade ago, when she โฆSee details»
News - Vivan Therapeutics
Jul 3, 2021ย ยท What's new at Vivan Therapeutics, and how we're helping patients and physicians make intelligent decisions about cancer treatment.See details»
Day in the Life of Laura Towart, Founder & Chief Executive Officer ...
Jun 14, 2022ย ยท Based at The WestWorks in White City Place, Vivan Therapeutics is the pioneer of a personalised cancer therapeutics platform, developed at Mount Sinai Medical Center in New โฆSee details»
Vivan Therapeutics Joins Repositive Cancer Model Network
Mar 4, 2021ย ยท Repositive has announced that Vivan Therapeutics will be the next company to join its global network of cancer model partners. With this new partnership, Repositive is โฆSee details»
Vivan Therapeutics Partners with Canadian Medical Provider โฆ
Oct 25, 2022ย ยท TORONTO & LONDON-- ( BUSINESS WIRE )-- Vivan Therapeutics (โVivanโ), a London-based biotechnology company, and Gotodoctor.ca, a leading Canadian healthcare โฆSee details»
Laura Towart - Founder and Chief Executive Officer @ VIVAN โฆ
Laura Towart is the Founder & CEO at Vivan Therapeutics. Laura Towart attended Joan & Sanford I. Weill Medical College of Cornell University.See details»
Perlara Enters Collaboration with Vivan for Multiple Rare Diseases
Jun 18, 2021ย ยท Perlara entered a collaboration with Vivan Therapeutics to identify personalized therapeutics for rare genetic diseases by screening FDA approved drugs and drug libraries โฆSee details»
Who we are - Vivan Therapeutics
Vivan Therapeutics' Personal Discovery Process provides individuals with personalised cancer treatment and cancer treatment research on an unprecedented scale.See details»
Perlara partners with Vivan Therapeutics to tackle rare genetic โฆ
Jul 1, 2021ย ยท Vivan Therapeutics develops personalised therapeutics for cancer & rare genetic diseases. For each patient or disease, we build a genetically matched fruit fly model of the โฆSee details»
Vivan Therapeutics | London - Facebook
Vivan Therapeutics, London, United Kingdom. 238 likes. Vivan Therapeutics is a London based biotechnology company offering cancer patients access to the most advanced personalised cancer therapeutics...See details»